AN2 Therapeutics, Inc. — Form D

AN2 Therapeutics, Inc. of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-25. The offering totals $40.0M, of which $40.0M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2026-03-25
Form: D
Accession: 0001880438-26-000001
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $40.0M
Amount sold: $40.0M
Investors: 16
Date of first sale: 2026-03-10
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-577698

Issuer

Name: AN2 Therapeutics, Inc.
CIK: 0001880438
Entity type: Corporation
Jurisdiction: DELAWARE
Address: 1300 EL CAMINO REAL, SUITE 100, MENLO PARK, CA, 94025
Phone: (650) 331-9090

Officers, directors & promoters (13)

Name	Role	Location
Kabeer S. Aziz	Director	MENLO PARK, CA
Eric Easom	Director	MENLO PARK, CA
Margaret Lynn FitzPatrick	Director	MENLO PARK, CA
Gilbert Lynn Marks	Director	MENLO PARK, CA
Patricia Lynn Martin	Director	MENLO PARK, CA
Rob S. Readnour	Director	MENLO PARK, CA
Melvin Lynn Spigelman	Director	MENLO PARK, CA
Stephanie Lynn Wong	Director	MENLO PARK, CA
Joseph S. Zakrzewski	Director	MENLO PARK, CA
Sanjay Chanda	Executive Officer	MENLO PARK, CA
Lucy Day	Executive Officer	MENLO PARK, CA
Eric Easom	Executive Officer	MENLO PARK, CA
Joshua Eizen	Executive Officer	MENLO PARK, CA

More